The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
Biophotonic composition for the treatment of otitis external
Cerquetella, Matteo;Tambella, Adolfo Maria;Spaterna, Andrea;
2020-01-01
Abstract
The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
patent US20200230101.pdf
accesso aperto
Tipologia:
Altro materiale allegato
Licenza:
DRM non definito
Dimensione
783.06 kB
Formato
Adobe PDF
|
783.06 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
